DossierENTITY

ADVANCE OUTCOMES

Coverage of ADVANCE OUTCOMES in the Nexus archive.

Earliest in view: Jul 31 · 12:53 UTCMost recent: Jul 31 · 12:53 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 31 · 12:53 UTCMEDPAGE TODAY
New Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win
Oral ralinepag may receive FDA approval after showing effectiveness in preventing worsening of pulmonary arterial hypertension in a phase III trial. The drug's success in the ADVANCE OUTCOMES trial could lead to its approval as a treatment for PAH.